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Introduction
Metastasis to the adrenal gland is a common compli-
cation of malignancy, with a reported incidence of
13–27%.1,2 These lesions are rarely clinically signifi-
cant, however, and massive adrenal hemorrhage into
the retroperitoneum with shock secondary to metas-
tasis is rare.3 We report a case of hepatocellular carci-
noma (HCC) with metastatic adrenal tumor bleeding.
Transarterial embolization (TAE) to stop tumor bleed-
ing was successful. Tumor resection with left adrena-
lectomy was performed after the embolization. The
clinical manifestations, diagnostic modalities, treatment
and prognosis for adrenal tumor bleeding are also
reviewed.
Case Report
A 37-year-old man presented to our emergency room in
March 2004 because of acute-onset dull pain in the
left flank radiating into the left upper abdomen. The
patient had not recently sustained any trauma. Past
history included chronic hepatitis B-related liver cirrho-
sis. In March 2002, he had visited our hospital because
of right-side abdominal pain. Computed tomography
(CT) scan at that time revealed a huge mass in the 
left hepatic lobe (Figure 1A), with a high level of 
α-fetoprotein (AFP; 61.83 ng/dL; reference range,
0.00–10.00) detected. From these findings, HCC in
the left hepatic lobe was strongly suspected, and a 
left hepatic lobectomy was performed in April 2002.
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Histopathologic examination confirmed HCC. Two
months after the operation, the AFP level had decreased
to within the normal range (7.63 ng/dL). At the 4-
month follow-up, however, the AFP level had increased
to 10.21 ng/dL. Diagnostic CT revealed a solitary
well-enhanced nodular mass with central necrosis in the
right adrenal gland, about 6 cm in diameter, strongly
suggestive of metastasis (Figure 1B). There was no 
evidence of recent hemorrhage inside the right adrenal
tumor. An endocrine survey revealed cortisol level of
18.3μg/mL (normal range, 4.0–12.0μg/mL), adreno-
corticotropic hormone of 22.6 pg/mL (normal range,
0.0 – 46.0 pg/mL) and 24-hour urine vanillylmandelic
acid of 1.1 mg/day (normal range, 1.5–7.5 mg/day).
As there was no evidence of other extrahepatic metasta-
sis or intrahepatic recurrence, the right adrenal tumor
was resected 4 months after the 1st operation. Pathologic
examination revealed adrenal metastasis of HCC.
AFP (3.59 ng/dL) decreased to within normal range
2 months after this operation. One year and 5 months
after the 2nd operation, however, AFP increased to
12.14 ng/dL again. CT and magnetic resonance
imaging (MRI) revealed a well-enhanced and well-
demarcated tumor (5 × 3 × 4 cm) with central necrosis
in the left adrenal gland and several intrahepatic nod-
ules, suggesting recurrence (Figure 1 C,D). There was
no evidence of recent hemorrhage inside the left adrenal
tumor. Although there was no further intervention,
the patient was followed up at the outpatient depart-
ment until March 2004, when the acute left flank pain
occurred. He appeared to be in moderate distress
from left flank pain, with pulse rate 71 beats/minute,
blood pressure 109/63 mmHg, temperature 35.9°C,
and respiration 18breaths/minute. Inspection of the
abdomen revealed 1 surgical scar in the shape of an
inverse Y over the upper abdomen and another linear
surgical scar over the right flank. The patient had mod-
erate abdominal tenderness with guarding over the
left flank and left upper abdomen. Rebound pain was
also noted. There was no palpable mass. The remainder
of the physical examination was unremarkable. White
cell count was 10,120/mm3, and urinalysis was normal.
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Figure 1. (A) Tumor shadow with low density is visible (arrowhead) during computed tomography (CT), delayed phase, of the primary
hepatic lesion. (B) CT before the 2nd operation shows right adrenal tumor (arrowhead). (C) CT before the 3rd operation shows left adre-
nal tumor (arrowhead). (D) Magnetic resonance imaging before the 3rd operation shows intrahepatic nodules (arrowheads). 
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Hemoglobin was 14.1 g/dL, but this fell to 8.9 g/dL
within the first 24 hours. CT showed enlargement of
the left adrenal gland with ill-defined contour and
surrounding hematoma formation in the left perirenal
fascia and splenic hilum up to the left subdiaphragmatic
space. Contrast-enhanced CT also showed areas of
higher density within the mass, suggestive of active
bleeding (Figure 2). Transfemoral abdominal angiog-
raphy was used to identify the bleeding site (Figure 3A).
Coil embolization in the bleeding vessels, specifically
branches of the left suprarenal artery, was performed
(Figure 3B), with active bleeding successfully con-
trolled. Another operation was performed 5 days after
the embolization for evacuation of the hematoma and
excision of the adrenal gland, which showed tumorous
changes. Immediately after the surgery, cortisol sup-
plementation was initiated according to the following
daily regimen: operation to postoperative day 2, 100mg
hydrocortisone (intravenous); postoperative days 3–7,
15 mg prednisolone tablet daily; after postoperative
day 7, 10 mg prednisone tablet daily. Histopathologic
examination revealed metastatic cancer cells in the left
adrenal tumor similar to HCC. When the histologic
findings for specimens from the primary HCC and the
metastatic left and right adrenal tumors were compared,
there was no definite differentiation of tumor cells
(Figure 4). The postoperative course was uneventful,
with the patient discharged on postoperative day 28,
and steroid hormone replacement with prednisolone
10 mg/day prescribed. TAE for recurrent HCC was
arranged after the 3rd operation, and the patient was still
alive at follow-up 18 months after the 3rd operation
(Figure 5).
Discussion
Usually discovered incidentally in autopsy studies,
metastatic lesions to the adrenal glands are rarely 
clinically significant, however, up to 27% of deceased 
cancer patients are found to harbor adrenal metas-
tases.2 With the continuing development of imaging
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Figure 2. Computed tomography (CT) of adrenal tumor bleeding.
(A) Nonenhanced CT shows an inhomogeneous, mixed-density
adrenal mass with extensive perirenal changes (arrowhead) and
high-density fluid accumulation below the left diaphragm (arrow).
(B, C) Contrast-enhanced CT shows areas of higher density within
the mass (arrow), suggestive of active bleeding.
J Chin Med Assoc • March 2007 • Vol 70 • No 3 129
Metastatic adrenal tumor bleeding from hepatoma
A B
Figure 3. Angiographic embolization. (A) Bleeding site was found by angiography (arrowhead). (B) Coil embolization was performed in
the bleeding vessels, specifically branches of the left suprarenal artery, successfully stopping the bleeding (arrowhead).
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Figure 4. Comparison of microscopic findings in specimens obtained during the 1st and 3rd operations. (A) First operation: primary
hepatic lesion (hematoxylin & eosin [H&E], 100×). (B) Third operation: metastatic tumor (arrow) within the left adrenal capsule (arrow-
heads) (H&E, 40×). (C) Close-up of bile in the bile canaliculi (arrowheads) (H&E, 400×).
techniques, an increasing number of adrenal metastases
are being detected incidentally during follow-up or 
at the time of initial presentation.4 In this case, the
AFP value was useful for detecting adrenal metastasis.
Sequential follow-up evaluation of tumor markers and
diagnostic imaging is essential for the early detection
of metastatic lesions.
Adrenal metastasis rarely produces symptoms.5
However, our patient presented with acute-onset
severe left flank and back pain, accompanied by a fall
in the hemoglobin level, due to adrenal hemorrhage.
The major clinical manifestations of adrenal hemor-
rhage depend on whether 1 or both adrenal glands
are involved, if their function is partially or completely
destroyed, and the extent of the protrusion/contain-
ment of the hemorrhage within the adrenal glands.
Signs and symptoms may include severe pain in the
upper abdomen of abrupt onset, usually radiating to
the flank, occasionally with diaphragmatic irritation.
There may be signs of peritoneal irritation, especially
when blood enters the peritoneal cavity. Shock and
decreasing hemoglobin concentration may occur, but
not invariably.6
We selected CT as the first choice of diagnostic
modality because of its unique ability to identify tissue
densities characteristic of blood, fat and so forth.7
Typically, CT findings show an inhomogeneous, mixed-
density adrenal mass with extensive perirenal changes.6
Acute bleeding is often identified as areas of higher
density within the mass on contrast-enhanced CT.8
Report of bilateral adrenalectomy for HCC metas-
tases is rare. It is of interest to discuss the therapeutic
strategy for such cases, however. Metastasis of HCC to
the adrenal gland, which is the 2nd most common site of
hematogenous spread after the lung, has been reported
in 8.4% of cases on autopsy.9 With improved imaging
modalities, metastatic adrenal tumors can be identified
at an early stage before spread to any other part of the
body. The discovery of adrenal metastasis in patients
with primary tumor automatically transfers them to an
advanced stage.3 Recent advances in the diagnostic
and therapeutic modalities used for many tumors have
resulted in increased life expectancies in some cancer
patients,3,10,11 and increased the clinical significance
of distant metastases. Therefore, it is possible to improve
the prognosis of adrenal metastasis from HCC through
multidisciplinary treatment. Therapeutic modalities
should be chosen according to each individual’s 
clinical features, including the size of the metastatic
tumor, whether there is invasion into the inferior vena
cava, function of the remaining liver, and the exis-
tence of intrahepatic and/or nonadrenal extrahepatic
lesions.12,13
Several treatment modalities are available for 
adrenal metastasis from HCC, such as adrenalectomy,
TAE, percutaneous ethanol injection therapy (PEIT)
and radiation therapy. With respect to TAE, the adre-
nal gland has 3 feeder arteries (inferior phrenic artery,
abdominal aorta, renal artery), making it difficult to
perform complete TAE for adrenal tumors.12 The
US-guided PEIT technique not only involves techni-
cal difficulties with respect to puncture of a small nodule
situated deep in the back behind the cirrhotic liver, but
also carries a risk of tumor seeding via the needle tract
or bleeding from the punctured tumor.12 The effect of
radiation therapy on adrenal metastasis was uncertain
in the past,13 however, some progress has been achieved
recently with respect to advancement of this therapeu-
tic modality. Adrenal metastases from HCC are sensi-
tive to radiation treatment. Radiation therapy (50 Gy)
for adrenal gland metastases is good palliative therapy
for pain relief, providing reasonable safety.14 Surgical
resection is indicated when the extrahepatic recurrence
is solitary and intrahepatic recurrence is not found; at
this stage, it is also the only way to achieve long-term
disease-free survival.12,13 Since patients with an adre-
nal mass are at risk for hemorrhage into the adrenal
gland in the event of tumor growth, the prevention 
of massive adrenal hemorrhage may prolong their sur-
vival and enhance quality of life.15 Based on the encour-
aging 18-month survival achieved in our patient after
treatment for metastatic adrenal tumor hemorrhage, it
appears reasonable to suggest aggressive surgical treat-
ment for HCC and its adrenal metastasis if intrahepatic
recurrence and/or other extrahepatic metastases are
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Figure 5. Timing of resection of hepatocellular carcinoma (HCC)/
adrenalectomy/transarterial embolization (TAE) and serial changes
in serum α-fetoprotein (AFP) levels.
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controlled. If other lesions are not so well controlled,
however, interventional therapies such as TAE, PEIT
and radiation therapy would be the treatment of choice
for adrenal metastasis from HCC.13,16
When the left-side adrenal tumor bleeding was
detected in our case, supportive transfusions and TAE
were selected as the first choice of treatment because:
(1) clinically significant adrenal hemorrhage secondary
to metastasis is rare, and most of the reported patients
were stabilized hemodynamically after transfusions and
required no further surgical intervention;3 (2) massive
bleeding from an adrenal metastasis requires surgical
laparotomy for hemostasis,3 however, acute surgical
removal of an adrenal tumor within a large retroperi-
toneal hematoma should be avoided as proper onco-
logic resection may not be possible under such
conditions;17 and (3) in patients with active bleeding,
angiographic embolization is a valuable adjunct for
achievement of hemostasis, allowing further workup
of the adrenal tumor and improvement in the effec-
tiveness of subsequent oncologic resection.17–20 In
this case, the clinical course of massive tumor bleeding
from adrenal metastasis shows the efficacy of embo-
lization with respect to achievement of hemostasis prior
to subsequent tumor resection, however, the clinical
significance of this strategy can be evaluated only after
further long-term follow-up of a relatively large number
of patients.
Metastatic adrenal tumor bleeding should be sus-
pected in HCC patients who suffer abrupt flank pain
and shock. CT scan is suggested as initial screening for
probable bleeding focus. Hemodynamically unstable
patients require supportive transfusions and urgent sur-
gical exploration. Angiographic embolization, if deemed
feasible, may be a valuable adjunct for achievement of
hemostasis prior to definite surgery.
References
1. Glomset DA. Incidence of metastasis of malignant tumors to
the adrenals. Am J Cancer 1938;32:57–61.
2. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma:
analysis of 1000 autopsied cases. Cancer 1950;3:74–85.
3. Lam KY, Lo CT. Metastatic tumours of the adrenal glands: a
30-year experience in a teaching hospital. Clin Endocrinol 2002;
56:95–101.
4. Berte SJ. Spontaneous adrenal hemorrhage in the adult: liter-
ature review and report of two cases. Ann Intern Med 1953;
38:28–37.
5. Siekavizza JL, Bernardino ME, Samaan NA. Suprarenal mass
and its differential diagnosis. Urology 1981;18:625–32.
6. Shah HR, Love L, Williamson MR, Buckner BC, Ferris EJ.
Hemorrhagic adrenal metastases: CT findings. J Comput Assist
Tomogr 1989;13:77–81.
7. Swift DL, Lingman JE, Baum WC. Spontaneous retroperi-
toneal hemorrhage: a diagnostic challenge. J Urol 1980;123:
577–81.
8. Liu L, Haskin ME, Rove LI, Bemis CE. Diagnosis of bilateral
adrenocortical hemorrhage by computed tomography. Ann
Intern Med 1982;97:720–1.
9. Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi R,
Sakamoto K, Ikari T. Pathology of hepatocellular carcinoma 
in Japan. Cancer 1982;51:863–77.
10. Lin CP, Yu HC, Cheng JS, Lai KH, Lo GH, Hsu PI, Lin CK,
et al. Clinical effects of intra-arterial infusion chemotherapy
with cisplatin, mitomycin C, leucovorin and 5-flourouracil for
unresectable advanced hepatocellular carcinoma. J Chin Med
Assoc 2004;67:602–10.
11. Huo TI, Huang YH, Wu JC. Percutaneous ablation therapy
for hepatocellular carcinoma: current practice and future per-
spectives. J Chin Med Assoc 2005;68:155–9.
12. Sakamoto Y, Kubuto K, Mori M, Inoue K, Abe H, Harihara Y,
Bandai Y, et al. Surgical management for adrenal gland metas-
tasis of hepatocellular carcinoma. Hepatogastroenterol 1999;
46:1036–41.
13. Momoi H, Shimahara Y, Terajima H, Iimuro Y, Yamamoto N,
Yamamoto Y, Ikai I, et al. Management of adrenal metastasis
from hepatocellular carcinoma. Surg Today 2002;32:1035–41.
14. Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, 
et al. Radiation therapy for adrenal tumor gland metastases from
hepatocellular carcinoma. Jpn J Clin Oncol 2005;35:61–7.
15. Seidenwurm DJ, Elmer EB, Kaplan LM, Williams EK, Morris
DG, Hoffman AR. Metastases to adrenal glands and the devel-
opment of Addison’s disease. Cancer 1984;54:552–7.
16. Morimoto T, Honda G, Oh Y, Ozaki N, Iimuro Y, Yamamoto Y,
Sakai Y, et al. Management of adrenal metastasis of hepatocellular
carcinoma by synchronous resection of bilateral adrenal glands.
J Gastroenterol 1999;34:132–7.
17. Hendrickson RJ, Katzman PJ, Queiroz R, Sitzmann JV,
Koniaris LG. Management of massive retroperitoneal hemor-
rhage from an adrenal tumor. Endocr J 2001;48:691–6.
18. Chng SM, Lin MB, Ng FC, Chng HC, Khoo TK. Adrenal
myelolipoma presenting with spontaneous retroperitoneal haem-
orrhage demonstrated on computed tomography and angio-
gram: a case report. Ann Acad Med Singapore 2002;31:
228–30.
19. Park JH, Kang KP, Lee SJ, Kim CH, Park TS, Baek HS. 
A case of a ruptured pheochromocytoma with an intratumoral
aneurysm managed by coil embolization. Endocr J 2003;50:
653–6.
20. Nakajo M, Onohara S, Shinmura K, Fujiyoshi F, Nakajo M.
Embolization for spontaneous retroperitoneal hemorrhage from
adrenal myelolipoma. Radiat Med 2003;21:214–9.
